April 5 (Reuters) - Abcellera Biologics Inc ABCL.O :
* PUBLISHED PEER-REVIEWED DATA DEMONSTRATE BAMLANIVIMAB'S HIGH POTENCY AGAINST SARS-COV-2
April 5 (Reuters) - Abcellera Biologics Inc ABCL.O :
* PUBLISHED PEER-REVIEWED DATA DEMONSTRATE BAMLANIVIMAB'S HIGH POTENCY AGAINST SARS-COV-2